INTERFERONI in English translation

• interferons
• interferon

Examples of using Interferoni in Slovenian and their translations into English

spodbujajo kemotaksi in interferoni z protivirusnim delovanjem,
chemokines that promote chemotaxis; and interferons that have anti-viral effects,

ga izzove kemični stimulant), in interferoni s protivirusnim delovanjem,
chemokines that promote chemotaxis; and interferons that have anti-viral effects,

Nekateri primeri interferonov za zdravljenje MS vključujejo IFN Beta-1a in IFN Beta-1b.
Other examples of injectable medications are growth hormone and interferon beta-1a.

Izpostavljenost interferonu beta je ekvivalentna po subkutani ali intramuskularni uporabi zdravila Rebif.
Subcutaneous and intramuscular administrations of Rebif produce equivalent exposure to interferon beta.

Razpolovni čas peginterferona beta-1a v serumu je daljši kot pri nepegiliranem interferonu beta-1a.
The serum half-life of peginterferon beta-1a is prolonged compared with non-pegylated interferon beta-1a.

Velja za skupino zdravil, ki vsebujejo interferone- glejte Pljučna arterijska hipertenzija spodaj.
Class label for interferon products, see below Pulmonary arterial hypertension.

Protivirusno pripravki za novorojenčke temeljijo na interferonu.
Antiviral preparations for newborns are based on interferon.

Tablete"Taktivin","Interferon", ki povečujejo odpornost proti tujim mikrobom;
Tablets Taktivin, Interferonthat increase immunity from foreign microbes.

Peginterferon alfa-2b je podoben interferonu alfa-2b, ki je v Evropski uniji(EU) na voljo že več let.
Peginterferon alfa-2b is similar to interferon alfa-2b, which has been available in the European Union(EU) for a number of years.

Peginterferon alfa- 2a je zelo podoben interferonu alfa- 2a, ki je že na voljo v Evropski uniji(EU) pod imenom Roferon.
Peginterferon alfa-2a is very similar to interferon alfa-2a, which is already available in the European Union(EU) as Roferon.

Peginterferon alfa- 2b je podoben interferonu alfa- 2b, ki je že na voljo v Evropski uniji(EU) kot IntronA.
Peginterferon alfa-2b is similar to interferon alfa-2b, which is already available in the European Union(EU) as IntronA.

Večina neželenih učinkov, opaženih pri interferonu beta-1a, je običajno blagih
The majority of adverse reactions observed with interferon beta-1a are usually mild

Pri raku ledvic je dodajanje zdravila Avastin interferonu alfa- 2a podaljšalo čas preživetja brez napredovanja bolezni s 5, 4 na 10, 2 meseca.
In kidney cancer, adding Avastin to interferon alfa-2a increased the progression-free survival time from 5.4 to 10.2 months.

je podobna kot pri interferonu alfa- 2a.
is similar to that seen with interferon alfa-2a.

Po intravenskem dajanju je končna razpolovna doba peginterferona alfa- 2a pri zdravih ljudeh približno 60 do 80 ur v primerjavi s 3 do 4 urami pri standardnem interferonu.
After intravenous administration, the terminal half-life of peginterferon alfa-2a in healthy subjects is approximately 60 to 80 hours compared to values of 3-4 hours for standard interferon.

Virus ni imel časa razvijati odpornosti proti komponentam generičnih zdravil, za razliko od interferonov, katerih zdravljenje se danes šteje za neučinkovito.
The virus did not have time to develop resistance to the components of generics, unlike interferon, treatment which is now considered ineffective.

V okviru druge študije so pri 1 171 bolnikih opazovali u inek dodajanja zdravila Tysabri interferonu beta- 1a(drugemu zdravilu, ki se uporablja pri MS).
The second study looked at the effect of adding Tysabri to interferon beta-1a(another medicine used in MS) in 1,171 patients.

V drugi študiji so pri 1 171 bolnikih primerjali učinke zdravila Tysabri z učinki placeba, ki so ju dodali interferonu beta-1a.
The second study compared the effect of Tysabri with that of placebo when added to interferon beta-1a in 1,171 patients.

Farmakokinetični profil zdravila AVONEX je bil preučen posredno, z analizo, ki je merila protivirusno aktivnost interferonov.
The pharmacokinetic profile of AVONEX has been investigated indirectly with an assay that measures interferon antiviral activity.

tudi imunomodulatorji in induktorji sinteze interferonov.
as well as immunomodulators and inducers of interferon synthesis.